Stratagene to Present at the Pacific Growth Equities Life Sciences Growth Conference
June 06 2006 - 4:38PM
Business Wire
Stratagene Corporation (NASDAQ:STGN) today announced that it will
present at the Pacific Growth Equities Life Sciences Growth
Conference, which will take place at the InterContinental Mark
Hopkins Hotel in San Francisco on Tuesday, June 13, 2006. The
presentation, which is scheduled for 12:30 p.m. Pacific Time, will
include a review of the Company's business strategy and historical
financial results. A live audio-only webcast of the presentation
will be broadcast via the internet. Those interested in listening
to the webcast will find a link to the webcast registration page on
Stratagene's website, www.stratagene.com. An archived replay of the
presentation will also be available approximately one hour
following the live presentation and may be accessed at
www.stratagene.com. About Stratagene Corporation Stratagene is a
developer, marketer and manufacturer of specialized life science
research and diagnostic products. The Company's life science
research unit supports advances in science by inventing,
manufacturing and distributing products that simplify, accelerate
and improve research. These products are used throughout the
academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery
and toxicology. The Company's diagnostic unit develops and
manufactures products for urinalysis, and high quality automated
instrument and reagent systems that use blood samples to test for
more than 1,000 different allergies and autoimmune disorders. In
addition, by combining its expertise in diagnostics and molecular
biology, as well as its experience with FDA regulatory procedures,
the Company is pursuing opportunities to expand its product
portfolio to include molecular diagnostic kits and instrumentation.
More information is available at www.stratagene.com.
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Oct 2023 to Oct 2024